| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |